HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The connection between lymphangiogenic signalling and prostaglandin biology: a missing link in the metastatic pathway.

Abstract
Substantial evidence supports important independent roles for lymphangiogenic growth factor signaling and prostaglandins in the metastatic spread of cancer. The significance of the lymphangiogenic growth factors, vascular endothelial growth factor (VEGF)-C and VEGF-D, is well established in animal models of metastasis, and a strong correlation exits between an increase in expression of VEGF-C and VEGF-D, and metastatic spread in various solid human cancers. Similarly, key enzymes that control the production of prostaglandins, cyclooxygenases (COX-1 and COX-2, prototypic targets of Non-steroidal anti-inflammatory drugs (NSAIDs)), are frequently over-expressed or de-regulated in the progression of cancer. Recent data have suggested an intersection of lymphangiogenic growth factor signaling and the prostaglandin pathways in the control of metastatic spread via the lymphatic vasculature. Furthermore, this correlates with current clinical data showing that some NSAIDs enhance the survival of cancer patients through reducing metastasis. Here, we discuss the potential biochemical and cellular basis for such anti-cancer effects of NSAIDs through the prostaglandin and VEGF signaling pathways.
AuthorsTara Karnezis, Ramin Shayan, Stephen Fox, Marc G Achen, Steven A Stacker
JournalOncotarget (Oncotarget) Vol. 3 Issue 8 Pg. 893-906 (Aug 2012) ISSN: 1949-2553 [Electronic] United States
PMID23097685 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
Chemical References
  • Anti-Inflammatory Agents, Non-Steroidal
  • Prostaglandins
  • VEGFC protein, human
  • Vascular Endothelial Growth Factor C
  • Vascular Endothelial Growth Factor D
  • Cyclooxygenase 1
  • Cyclooxygenase 2
  • PTGS1 protein, human
  • PTGS2 protein, human
Topics
  • Anti-Inflammatory Agents, Non-Steroidal (pharmacology, therapeutic use)
  • Cyclooxygenase 1 (biosynthesis)
  • Cyclooxygenase 2 (biosynthesis)
  • Humans
  • Lymphangiogenesis
  • Lymphatic Metastasis
  • Lymphatic System (blood supply)
  • Lymphatic Vessels (metabolism, pathology)
  • Neoplasms (metabolism, pathology)
  • Prostaglandins (metabolism)
  • Signal Transduction
  • Vascular Endothelial Growth Factor C (metabolism)
  • Vascular Endothelial Growth Factor D (biosynthesis, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: